Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q44709331)
Watch
English
Fungus-free versus disease-free nails
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
title
Fungus-free versus disease-free nails
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
author name string
Ernst Epstein
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
language of work or name
English
0 references
publication date
1 January 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
published in
Journal of the American Academy of Dermatology
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
volume
50
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
page(s)
151-2; author reply 152-3
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
cites work
Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2900339-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2900339-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2900339-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2900339-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2900339-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0190-9622(03)00339-6
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
PubMed ID
14699392
1 reference
stated in
Europe PubMed Central
PubMed ID
14699392
retrieved
5 December 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
